- Home
- PRA vs NEO Comparison
PRA vs NEO Comparison
Compare PRA & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRA | NEO |
|---|---|---|
| Founded | 1976 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2000 | 2008 |
Fundamental Metrics
Financial Performance| Metric | PRA | NEO |
|---|---|---|
| Price | $24.72 | $11.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $25.00 | $13.38 |
| AVG Volume (30 Days) | 1.0M | ★ 1.2M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $1,098,028,000.00 | N/A |
| Revenue This Year | N/A | $10.63 |
| Revenue Next Year | N/A | $9.73 |
| P/E Ratio | $154.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.79 | $4.72 |
| 52 Week High | $24.85 | $13.74 |
Technical Indicators
Market Signals| Indicator | PRA | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 57.13 | 68.27 |
| Support Level | $24.50 | $7.50 |
| Resistance Level | $24.74 | $11.41 |
| Average True Range (ATR) | 0.22 | 0.55 |
| MACD | 0.06 | 0.13 |
| Stochastic Oscillator | 92.83 | 78.55 |
Price Performance
Historical ComparisonAbout PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in four segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.